Last week we did a follow-up webinar on liquid biopsy. In the extended analysis it became apparent that lung cancer is the focus of liquid biopsy. While breast cancer shows up on the top of this list, the combination of NSCLC and lung cancer surpasses breast cancer by 11 biomarkers in use for liquid biopsies.
